{"altmetric_id":16678584,"counts":{"readers":{"mendeley":11,"citeulike":0,"connotea":0},"total":{"posts_count":1},"policy":{"unique_users_count":1,"unique_users":["nap"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa4eb3cf058f6100026c4","authors":["Florence Kanakoudi-Tsakalidou","Vasiliki Tzimouli","Polyxeni Pratsidou-Gertsi","Evanthia Chronopoulou","Maria Trachana"],"doi":"10.1016\/j.cyto.2008.01.007","first_seen_on":"2017-02-23T12:00:47+00:00","handles":[],"isbns":[],"issns":["10434666"],"journal":"Cytokine","last_mentioned_on":1325376000,"links":["http:\/\/dx.doi.org\/10.1016\/j.cyto.2008.01.007"],"pmid":"18445529","pubdate":"2008-06-01T00:00:00+00:00","publisher_subjects":[{"name":"Immunology","scheme":"era"}],"scopus_subjects":["Life Sciences","Medicine","Health Sciences","Immunology and Microbiology","Biochemistry, Genetics and Molecular Biology"],"subjects":["allergyandimmunology"],"title":"The significance of persistent newly developed autoantibodies in JIA patients under long-term anti-TNF treatment","type":"article","uri":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466608000082","mendeley_url":"http:\/\/www.mendeley.com\/research\/significance-persistent-newly-developed-autoantibodies-jia-patients-under-longterm-antitnf-treatment"},"altmetric_score":{"score":3,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":7260942,"mean":6.3644043817428,"rank":1726585,"this_scored_higher_than_pct":63,"this_scored_higher_than":4601392,"rank_type":"exact","sample_size":7260942,"percentile":63},"similar_age_3m":{"total_number_of_other_articles":91652,"mean":12.778003033246,"rank":29894,"this_scored_higher_than_pct":65,"this_scored_higher_than":59969,"rank_type":"exact","sample_size":91652,"percentile":65},"this_journal":{"total_number_of_other_articles":799,"mean":1.7838070175439,"rank":67,"this_scored_higher_than_pct":81,"this_scored_higher_than":654,"rank_type":"exact","sample_size":799,"percentile":81},"similar_age_this_journal_3m":{"total_number_of_other_articles":19,"mean":4.0377777777778,"rank":6,"this_scored_higher_than_pct":63,"this_scored_higher_than":12,"rank_type":"exact","sample_size":19,"percentile":63}}},"demographics":{"users":{"mendeley":{"by_status":{"Professor > Associate Professor":1,"Researcher":2,"Student  > Ph. D. Student":2,"Other":2,"Student  > Master":2,"Student  > Bachelor":2},"by_discipline":{"Medicine and Dentistry":6,"Agricultural and Biological Sciences":2,"Biochemistry, Genetics and Molecular Biology":2,"Unspecified":1}}},"geo":{"mendeley":{"CA":1,"DE":1}}},"posts":{"policy":[{"title":"Safe and Effective Medicines for Children: Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act","url":"https:\/\/www.nap.edu\/download\/13311","license":"public","citation_ids":[16678531,16678532,185476,203807,195422,173813,181578,16678535,16678540,16678541,16678542,16678544,2432132,835182,487379,16678546,16678547,16678548,16678549,16678550,16678551,16678552,16678554,16678555,176292,16678556,16678557,2840743,7656666,16678558,521281,16678559,3124089,5094112,16678560,16678561,2191144,1548315,16678562,4842900,534072,20480474,4609308,16678563,530417,16678565,864582,16678566,16678567,1599585,530556,1374735,16678568,3176830,16678569,16678570,11761661,16678574,2191150,16678575,16678577,3516885,16678578,20480478,16678579,16678581,146487,16678582,5530992,166462,3424357,2266819,16678584,111951,16678585,16678586,16678587,16678588,3465253,163392,16678589,16678590,16678591,1174793,5414513,16678592,16678593,2943676,16678594,16678596,16678598,16678602,16678603,16678606,16678607,16678608,16678609,1366126,11992722,14930848,16678610,16678611,16678612,8252734,5730811,5755000,5794663,5730797,5799932,5582545,5767592,6847095,5732494,16678616,16678617,16678618,5791582,14980907,4673661,16678619,14977865,16678620,2576016,431833,14509307,14486434,16678621,5784053,4759323,16678622,2323607,14594057,2367252,563643,385688,4321705,697664,14486442,3368290,6701984,16678623,16678624,16678630,20480487,16678631,5808219,16678632,16678633,16678635,20480489,233109,16678636,16678637,1353934,16678638,16678639,173420,1546193,269175,1384109,20480490,16678640,16678643,16678646,1656323,20480491,16678648,425344,5821219,3849441,236360,436770,16678656,16678660,14486756,15205162,566495,5736366,16678666,5788182,16678668,7418787,16678672,211750,16678537,16678538,1271124,2931186,5791582,5801161,710481,236548,14930848,16678701,16678531,16678703,7619325,16678532,185476,16678705,16678706,203807,16678707,4377857,16678711,16678713,5728128,8951983,195422,4673661,952043,952041,173813,181578,16678535,14980907,9677749,1083961,2898386,4833877,4833877,4833877],"posted_on":"2012-01-01T00:00:00+00:00","source":{"name":"National Academies Press","description":"The US National Academies Press (NAP) was created by the National Academy of Sciences to publish the reports of the National Academies of Sciences, Engineering and Medicine, operating under a charter granted by the Congress of the United States. The NAP publishes on a wide range of topics in science, engineering, and medicine, providing authoritative information on important matters in science and health policy.","geo":{"country":"US"}},"page_url":"https:\/\/www.nap.edu\/catalog\/13311\/safe-and-effective-medicines-for-children-pediatric-studies-conducted-under","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-69e9034c735f8a556e7ae4de1049532bbade9502e72cb031436a78579eaa1b8b.jpg"}}]}}